Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.

A recent genome-wide association study (GWAS) performed by the The Wellcome Trust Case-Control Consortium based on 12 374 nonsynonymous single-nucleotide polymorphisms (SNPs) provided evidence for several genes involved in multiple sclerosis (MS) susceptibility. In this study, we aimed at verifying...

Full description

Bibliographic Details
Main Authors: Alcina, A, Ramagopalan, S, Fernández, O, Catalá-Rabasa, A, Fedetz, M, Ndagire, D, Leyva, L, Arnal, C, Delgado, C, Lucas, M, Izquierdo, G, Ebers, G, Matesanz, F
Format: Journal article
Language:English
Published: 2010
_version_ 1826260018881626112
author Alcina, A
Ramagopalan, S
Fernández, O
Catalá-Rabasa, A
Fedetz, M
Ndagire, D
Leyva, L
Arnal, C
Delgado, C
Lucas, M
Izquierdo, G
Ebers, G
Matesanz, F
author_facet Alcina, A
Ramagopalan, S
Fernández, O
Catalá-Rabasa, A
Fedetz, M
Ndagire, D
Leyva, L
Arnal, C
Delgado, C
Lucas, M
Izquierdo, G
Ebers, G
Matesanz, F
author_sort Alcina, A
collection OXFORD
description A recent genome-wide association study (GWAS) performed by the The Wellcome Trust Case-Control Consortium based on 12 374 nonsynonymous single-nucleotide polymorphisms (SNPs) provided evidence for several genes involved in multiple sclerosis (MS) susceptibility. In this study, we aimed at verifying the association of 19 SNPs with MS, with P-values < or =0.005, in an independent cohort of 732 patients and 974 controls, all Caucasian from the South of Spain. We observed an association of the rs17368528 polymorphism with MS (P=0.04, odds ratio (OR)=0.801, 95% confidence interval (CI)=0.648-0.990). The association of this polymorphism with MS was further validated in an independent set of 1318 patients from the Canadian Collaborative Project (P=0.04, OR=0.838, 95% CI=0.716-0.964). This marker is located on chromosome 1p36.22, which is 1 Mb away from the MS-associated kinesin motor protein KIF1B, although linkage disequilibrium was not observed between these two markers. The rs17368528 SNP results in an amino-acid substitution (proline to leucine) in the fifth exon of the hexose-6-phosphate dehydrogenase (H6PD) gene, in which some variants have been reported to attenuate or abolish H6PD activity, in individuals with cortisone reductase deficiency. This study corroborates the association of one locus determined by GWAS and points to H6PD as a new candidate gene for MS.
first_indexed 2024-03-06T18:58:59Z
format Journal article
id oxford-uuid:12df3047-299a-4bbc-b405-f96b748be7c1
institution University of Oxford
language English
last_indexed 2024-03-06T18:58:59Z
publishDate 2010
record_format dspace
spelling oxford-uuid:12df3047-299a-4bbc-b405-f96b748be7c12022-03-26T10:10:26ZHexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:12df3047-299a-4bbc-b405-f96b748be7c1EnglishSymplectic Elements at Oxford2010Alcina, ARamagopalan, SFernández, OCatalá-Rabasa, AFedetz, MNdagire, DLeyva, LArnal, CDelgado, CLucas, MIzquierdo, GEbers, GMatesanz, FA recent genome-wide association study (GWAS) performed by the The Wellcome Trust Case-Control Consortium based on 12 374 nonsynonymous single-nucleotide polymorphisms (SNPs) provided evidence for several genes involved in multiple sclerosis (MS) susceptibility. In this study, we aimed at verifying the association of 19 SNPs with MS, with P-values < or =0.005, in an independent cohort of 732 patients and 974 controls, all Caucasian from the South of Spain. We observed an association of the rs17368528 polymorphism with MS (P=0.04, odds ratio (OR)=0.801, 95% confidence interval (CI)=0.648-0.990). The association of this polymorphism with MS was further validated in an independent set of 1318 patients from the Canadian Collaborative Project (P=0.04, OR=0.838, 95% CI=0.716-0.964). This marker is located on chromosome 1p36.22, which is 1 Mb away from the MS-associated kinesin motor protein KIF1B, although linkage disequilibrium was not observed between these two markers. The rs17368528 SNP results in an amino-acid substitution (proline to leucine) in the fifth exon of the hexose-6-phosphate dehydrogenase (H6PD) gene, in which some variants have been reported to attenuate or abolish H6PD activity, in individuals with cortisone reductase deficiency. This study corroborates the association of one locus determined by GWAS and points to H6PD as a new candidate gene for MS.
spellingShingle Alcina, A
Ramagopalan, S
Fernández, O
Catalá-Rabasa, A
Fedetz, M
Ndagire, D
Leyva, L
Arnal, C
Delgado, C
Lucas, M
Izquierdo, G
Ebers, G
Matesanz, F
Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
title Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
title_full Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
title_fullStr Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
title_full_unstemmed Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
title_short Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
title_sort hexose 6 phosphate dehydrogenase a new risk gene for multiple sclerosis
work_keys_str_mv AT alcinaa hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT ramagopalans hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT fernandezo hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT catalarabasaa hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT fedetzm hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT ndagired hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT leyval hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT arnalc hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT delgadoc hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT lucasm hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT izquierdog hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT ebersg hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis
AT matesanzf hexose6phosphatedehydrogenaseanewriskgeneformultiplesclerosis